Analyst Ratings for Spark Therapeutics (ONCE) [Neutrals]

ONCE Rating Summary

  |   Expand Research on ONCE
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 2.1 / 10   Percentile Rank: 15%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
3/25/2019 Barclays Gena Wang Downgrade Equalweight
(Overweight)
115.00
(74.00)
113.27
(110.05)
-2.84% Details
3/7/2019 William Blair Raju Prasad Downgrade Market Perform
(Outperform)
N/A
(N/A)
113.70
(110.05)
-3.21% Details
Like ONCE Ratings? Also take a look at

ONCE Ratings News